Cargando…

The complementary role of histology and proteomics for diagnosis and typing of systemic amyloidosis

The tissue diagnosis of amyloidosis and confirmation of fibril protein type, which are crucial for clinical management, have traditionally relied on Congo red (CR) staining followed by immunohistochemistry (IHC) using fibril protein specific antibodies. However, amyloid IHC is qualitative, non‐stand...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rezk, Tamer, Gilbertson, Janet A, Mangione, P Patrizia, Rowczenio, Dorota, Rendell, Nigel B, Canetti, Diana, Lachmann, Helen J, Wechalekar, Ashutosh D, Bass, Paul, Hawkins, Philip N, Bellotti, Vittorio, Taylor, Graham W, Gillmore, Julian D
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2019
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6648380/ https://www.ncbi.nlm.nih.gov/pubmed/30740936 http://dx.doi.org/10.1002/cjp2.126

Ejemplares similares

Proteomic Analysis for the Diagnosis of Fibrinogen Aα-chain Amyloidosis
por: Taylor, Graham W., et al.
Publicado: (2019)

Empirical use of anakinra in AA amyloidosis of uncertain aetiology
por: Lane, T, et al.
Publicado: (2015)

Diagnostic value of fat aspirates for amyloidosis in 950 patients
por: Gilbertson, JA, et al.
Publicado: (2015)

Lysozyme amyloid: evidence for the W64R variant by proteomics in the absence of the wild type protein
por: Moura, Alexandra, et al.
Publicado: (2020)

Diagnostic sensitivity of abdominal fat aspiration in cardiac amyloidosis
por: Quarta, Candida Cristina, et al.
Publicado: (2017)

OR14-001 – Tocilizumab in autoinflammation and AA amyloidosis
por: Lane, T, et al.
Publicado: (2013)

Five novel TTR variants: associated phenotypes and structural consequences
por: Rowczenio, Dorota, et al.
Publicado: (2015)

Disease progression in cardiac transthyretin amyloidosis is indicated by serial calculation of National Amyloidosis Centre transthyretin amyloidosis stage
por: Law, Steven, et al.
Publicado: (2020)

Increasing the accuracy of proteomic typing by decellularisation of amyloid tissue biopsies
por: Mangione, P. Patrizia, et al.
Publicado: (2017)

PW01-021 – The phenotype of FMF due to deletion M694
por: Lachmann, HJ, et al.
Publicado: (2013)

Clinical ApoA‐IV amyloid is associated with fibrillogenic signal sequence
por: Canetti, Diana, et al.
Publicado: (2021)

Renal Amyloidosis Associated With 5 Novel Variants in the Fibrinogen A Alpha Chain Protein
por: Rowczenio, Dorota, et al.
Publicado: (2016)

Plasmin activity promotes amyloid deposition in a transgenic model of human transthyretin amyloidosis
por: Slamova, Ivana, et al.
Publicado: (2021)

Senile Systemic Amyloidosis: Clinical Features at Presentation and Outcome
por: Pinney, Jennifer H., et al.
Publicado: (2013)

DPD Scintigraphy for diagnosis of amyloidosis in 1191 patients– a single centre experience
por: Hutt, David, et al.
Publicado: (2015)

Characteristics and natural history of early-stage cardiac transthyretin amyloidosis
por: Law, Steven, et al.
Publicado: (2022)

Clinical symptoms and molecular investigations in 13 patients with Schnitzler syndrome identified at the single UK centre
por: Rowczenio, D, et al.
Publicado: (2015)

Diflunisal therapy for cardiac ATTR amyloidosis: a longitudinal, prospective, single centre study
por: Quarta, Candida C, et al.
Publicado: (2015)

Deletion in MEFV resulting in the loss of p.M694 residue as the cause of autosomal dominant familial Mediterranean fever in North Western European Caucasians - a case series and genetic exploration
por: Rowczenio, D, et al.
Publicado: (2015)

Systemic Amyloidosis in England: an epidemiological study
por: Pinney, Jennifer H, et al.
Publicado: (2013)

A novel mass spectrometry method to identify the serum monoclonal light chain component in systemic light chain amyloidosis
por: Sharpley, Faye A., et al.
Publicado: (2019)

Cardiac biomarkers are prognostic in systemic light chain amyloidosis with no cardiac involvement by standard criteria
por: Sharpley, Faye A., et al.
Publicado: (2020)

Early relapse is an adverse prognostic marker in systemic immunoglobulin light chain (AL) Amyloidosis
por: Ravichandran, Sriram, et al.
Publicado: (2022)

Patterns of late gadolinium enhancement in 94 patients with AL or transthyretin cardiac amyloidosis
por: Dungu, Jason, et al.
Publicado: (2012)

The Evolving Epidemiology of Amyloidosis
por: Wechalekar, Ashutosh D.
Publicado: (2021)

Impact of early response on outcomes in AL amyloidosis following treatment with frontline Bortezomib
por: Ravichandran, Sriram, et al.
Publicado: (2021)

Clinical Amyloid Typing by Proteomics: Performance Evaluation and Data Sharing between Two Centres
por: Canetti, Diana, et al.
Publicado: (2021)

Change in N-terminal pro-B-type natriuretic peptide at 1 year predicts mortality in wild-type transthyretin amyloid cardiomyopathy
por: Law, Steven, et al.
Publicado: (2022)

T1 mapping and survival in systemic light-chain amyloidosis
por: Banypersad, Sanjay M., et al.
Publicado: (2015)

Clinical Importance of Left Atrial Infiltration in Cardiac Transthyretin Amyloidosis
por: Bandera, Francesco, et al.
Publicado: (2022)

Karyomegalic interstitial nephritis with a novel FAN1 gene mutation and concurrent ALECT2 amyloidosis
por: Law, Steven, et al.
Publicado: (2020)

P910: DISPARATE PREDICTION OF OUTCOMES IN A UNIFORMLY TREATED COHORT OF PATIENTS WITH AL AMYLOIDOSIS STRATIFIED BY MAYO 2012 AND EUROPEAN CARDIAC STAGING SYSTEMS
por: Khwaja, Jahanzaib, et al.
Publicado: (2023)

PW02-014 - Long term outcome and quality of life in TRAPS
por: Lane, T, et al.
Publicado: (2013)

The impact and importance of achieving a complete haematological response prior to renal transplantation in AL amyloidosis
por: Cohen, Oliver C., et al.
Publicado: (2020)

Updates in Cardiac Amyloidosis: A Review
por: Banypersad, Sanjay M., et al.
Publicado: (2012)

Extensive cardiac FDG uptake in a patient with AL amyloidosis
por: Hatipoglu, Suzan, et al.
Publicado: (2023)

The Protein Network in Subcutaneous Fat Biopsies from Patients with AL Amyloidosis: More Than Diagnosis?
por: Di Silvestre, Dario, et al.
Publicado: (2023)

(99m)Tc-DPD scintigraphy in immunoglobulin light chain (AL) cardiac amyloidosis
por: Quarta, Candida Cristina, et al.
Publicado: (2021)

Rare Forms of Cardiac Amyloidosis: Diagnostic Clues and Phenotype in Apo AI and AIV Amyloidosis
por: Ioannou, Adam, et al.
Publicado: (2023)

Progression of echocardiographic parameters and prognosis in transthyretin cardiac amyloidosis
por: Chacko, Liza, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_a4i0jki3sfl58v4j3flbmrpbrl